BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2026.
World J Diabetes. Jan 15, 2026; 17(1): 114535
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.114535
Table 5 Comparison of peripheral neuromodulation techniques for glucose regulation
Category
Techniques
Primary targets/ depth
Mechanistic modality
Advantages& limitations
Potential population/stage
Non-invasive electrical stimulation[48-52,54,55,62]taVNS; pVNS; aVNSAuricular or cervical vagal branches (superficial/subcutaneous)Transcutaneous or percutaneous electrical activation of vagal afferent fibersSafe, inexpensive, easily repeatable; limited depth and targeting precisionMild hyperglycemia, impaired glucose tolerance, metabolic syndrome
Invasive electrical stimulation[53,61,63]eVNS; SCSCervical vagus trunk or thoracic dorsal column (deep)Implantable electrodes deliver direct neural modulation via electrical pulsesHigh precision and sustained effects; invasive surgery, infection riskAdvanced or refractory diabetes with neuropathic complications
Acoustic/mechanical neuromodulation[56-59]pFUS; LIPUS; USHepatic hilum, portal vein region, or peripheral nerve plexus (deep tissue)Mechanical stress on glucose-sensing afferents by focused ultrasoundNon-invasive, spatially selective, real-time image guidance; limited mechanistic resolutionObese or insulin-resistant individuals, early T2DM
Optogenetic neuromodulation[58-60]OSPancreatic parasympathetic fibers, hepatic vagal branches (experimental)Optical activation of genetically targeted neurons controlling endocrine outputHigh cellular specificity; requires genetic modification, currently preclinicalConceptual or experimental models of neural and metabolic coupling


Write to the Help Desk